Inovio to present at the 2023 jefferies healthcare conference

Plymouth meeting, pa. , may 25, 2023 /prnewswire/ -- inovio (nasdaq: ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-related diseases, cancer, and infectious diseases, today announced that dr. jacqueline shea, president and ceo, and dr. michael sumner, cmo, will present at the 2023 jefferies healthcare conference.
INO Ratings Summary
INO Quant Ranking